Clinical Trial Update: Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC). [Phase 2]

View source ↗

Summary

Phase 2 trial of pembrolizumab with paclitaxel and carboplatin in advanced epithelial ovarian cancer (and fallopian tube/peritoneal cancers) was terminated; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Peritoneal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: University of Miami | Conditions: Fallopian Tube Cancer, Peritoneum Cancer | Phase 2 | Status: TERMINATED | Results posted: 2023-11-07